20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22338 | 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide | GDC046 | Others , JAK |
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046), a potent lead analog, has good kinase selectivity, physicochemical properties and pharmacokinetic profile. | |||
T21694 | (R)-Lisofylline | (R)-Lisophylline | STAT |
(R)-Lisofylline ((R)-Lisophylline) is an inhibitor of lysophosphatidic acid acyltransferase (IC50 = 0.6 µM). (R)-Lisofylline interrupts IL-12 signaling-mediated STAT4 activation and can be used in studies about the treat... | |||
T3533 | Apilimod mesylate | STA 5326 mesylate | IL Receptor , PI3K , Interleukin |
Apilimod mesylate (STA 5326 mesylate) is a potent IL-12/IL-23 inhibitor. | |||
T9913 | Ustekinumab | Interleukin | |
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody. | |||
T2018 | Apilimod | STA 5326 | IL Receptor , PI3K , Interleukin |
Apilimod (STA 5326) inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis. | |||
T28958 | TG6-129 | TG6 129 | Prostaglandin Receptor |
TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 µM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and... | |||
T3765 | L-asarinin | (-)-Episesamin | Others |
L-asarinin ((-)-Episesamin) reduces peripheral blood concentration of IL-12 and inhibits the expression of CXCR3 and TLR4, which means Asarinin may have a role on the TLR4 pathway and produce prolongation of allograft he... | |||
T14687 | Deucravacitinib | BMS-986165 | Tyrosine Kinases , JAK , IFNAR , Interleukin |
Deucravacitinib (BMS-986165) inhibits IL-12/23 and type I IFN pathways[1][2]. BMS-986165 is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases. Which selectively bi... | |||
TN1787 | Isomucronulatol 7-O-glucoside | Isomucronulatol 7-O-beta-glucoside | Others |
Isomucronulatol 7-O-glucoside is a natural product | |||
T7649 | Tyrphostin A1 | AG9,Tyrphostin 1 | EGFR , Interleukin |
Tyrphostin A1 (Tyrphostin 1) is an inhibitor of EGFR tyrosine kinase . | |||
T3859 | Isomucronulatol | 7,2'-Dihydroxy-3',4'-dimethoxyisoflavan | Others |
Isomucronulatol (7,2'-Dihydroxy-3',4'-dimethoxyisoflavan) is a natural product | |||
TN1189 | 13-Methylberberine chloride | 13-Methylberberine | Others |
13-Methylberberine chloride shows anti-adipogenic effect on 3T3-L1 adipocytes, it has potential as an anti-obesity drug | |||
T2061 | APY0201 | PI3K , Interleukin | |
APY0201 is a effective, highly specific, ATP-competitive PIKfyve inhibitor (IC50: 5.2 nM). It can interrupt the conversion of phosphatidylinositol 3-phosphate (PtdIns3P) to PtdIns(3, 5)P2. | |||
T38294 | 4-Deoxypyridoxine hydrochloride | S1P Receptor | |
4-Deoxypyridoxine (4-DPD) is a vitamin B6 antimetabolite with diverse biological activities. It inhibits transport of pyridoxine , pyridoxal, and pyridoxamine in and reduces growth of S. carlsbergensis cells. 4-DPD inhib... | |||
T76935 | Briakinumab | ||
Briakinumab (ABT-874), a fully human anti-IL-12/23p40 monoclonal antibody, selectively targets and neutralizes IL-12 and IL-23. This compound is utilized in the research of various autoimmune disorders, including rheumat... | |||
T26280 | TL4-12 | TL4 12 | |
TL4-12 is a MAP4K2 (GCK) inhibitor that inhibits IL-1 and TGFβ-induced p38 MAPK phosphorylation in vitro. | |||
TP1978 | 11R-VIVIT | NFAT inhibitor, Cell Permeable | |
NFAT inhibitor. Inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). Also attenuates NO production and Nos2 mRNA expression in LPS-stimulated ... | |||
T78175 | JAK-IN-25 | JAK | |
JAK-IN-25 (compound 19), a potent JAK inhibitor, exhibits IC50 values of 6 nM for TYK2, 21 nM for JAK1, 8 nM for JAK2, and 1051 nM for JAK3. It also demonstrates an IC50 of 28 nM against human whole blood IL-12 (HEB IL-1... | |||
T70394 | Deucravacitinib HCl | ||
Deucravacitinib HCl is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bo... | |||
T62451 | TYK2-IN-12 | ||
TYK2-IN-12 (compound 30) is a selective, orally active inhibitor of TYK2 (tyrosine kinase 2) (Ki: 0.51 nM). TYK2-IN-12 inhibits IL-12-induced IFNγ in human and mouse whole blood with IC50 values of 2.7 and 7.0 μM, respec... |